Boji Medical Technology Co.,Ltd. (SHE:300404)
China · Delayed Price · Currency is CNY 12.68
-0.29 (-2.24%)
At close: Sep 2, 2026
Boji Medical Technology Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 285.99 | 326.21 | 270.13 | 397.16 | 306.93 | 384.52 |
Trading Asset Securities | 122.3 | 55.37 | 23.68 | 7.38 | 45.69 | 20 |
Cash & Short-Term Investments | 408.29 | 381.58 | 293.81 | 404.54 | 352.62 | 404.52 |
Cash Growth | 26.84% | 29.87% | -27.37% | 14.72% | -12.83% | 155.12% |
Accounts Receivable | 336.56 | 317.71 | 261.83 | 177.07 | 146.92 | 103.15 |
Other Receivables | 12.84 | 11.07 | 10.07 | 7.89 | 6.87 | 5.14 |
Receivables | 349.4 | 328.78 | 271.9 | 184.96 | 153.79 | 108.28 |
Inventory | 244.9 | 228.04 | 189.49 | 199.07 | 168.36 | 148.3 |
Other Current Assets | 28.96 | 22.33 | 25.08 | 26.61 | 26.45 | 39 |
Total Current Assets | 1,032 | 960.72 | 780.28 | 815.18 | 701.21 | 700.1 |
Property, Plant & Equipment | 208.85 | 218.12 | 235.05 | 334.74 | 301.74 | 225.78 |
Long-Term Investments | 162.36 | 153.41 | 154.47 | 114.04 | 104.41 | 81.39 |
Goodwill | 28.1 | 28.1 | 28.1 | 28.1 | 28.1 | 28.1 |
Other Intangible Assets | 20.42 | 24.57 | 21.32 | 21.93 | 22.36 | 22.5 |
Long-Term Deferred Tax Assets | 80.09 | 78.31 | 66.47 | 48.13 | 34.57 | 23.9 |
Long-Term Deferred Charges | 15.24 | 16.07 | 20.01 | 16.24 | 12.36 | 4.76 |
Other Long-Term Assets | 149.12 | 150.13 | 144.9 | 50.57 | 60.67 | 51.69 |
Total Assets | 1,696 | 1,629 | 1,451 | 1,429 | 1,265 | 1,138 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 187.27 | 176.58 | 127.76 | 101.45 | 79.04 | 55.8 |
Accrued Expenses | 28.05 | 31.48 | 26.9 | 24.51 | 20.27 | 14.51 |
Short-Term Debt | 6.06 | 4.8 | 1.6 | 29.88 | 20.23 | 25.21 |
Current Portion of Long-Term Debt | 3.1 | 1.93 | 1.42 | 1.93 | 0.55 | - |
Current Portion of Leases | - | 1.32 | 2.3 | 2.07 | 2.02 | 1.61 |
Current Income Taxes Payable | 8.67 | 4.61 | 3.86 | 1.57 | 1.56 | 6.58 |
Current Unearned Revenue | 249.85 | 259.96 | 195.96 | 176.57 | 163.19 | 155.9 |
Other Current Liabilities | 55.06 | 44.65 | 37.72 | 19.53 | 13.33 | 11.24 |
Total Current Liabilities | 538.07 | 525.33 | 397.51 | 357.51 | 300.19 | 270.84 |
Long-Term Debt | 33.77 | 34.73 | 39.26 | 74.63 | 54.25 | - |
Long-Term Leases | 0.41 | 1.02 | 1.55 | 3.1 | 3.78 | 4.68 |
Long-Term Unearned Revenue | 3.84 | 3.92 | 5.34 | 7.48 | 11.9 | 12.28 |
Long-Term Deferred Tax Liabilities | 4.61 | 4.51 | 4.79 | 5.72 | 6.2 | 3.65 |
Other Long-Term Liabilities | 0.38 | 0.38 | 0.38 | 0.38 | 0.38 | 0.38 |
Total Liabilities | 581.08 | 569.88 | 448.84 | 448.82 | 376.71 | 291.83 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 385.75 | 385.73 | 382.44 | 382 | 368.39 | 261.46 |
Additional Paid-In Capital | 401.81 | 390.61 | 367.98 | 361.57 | 291.25 | 382.78 |
Retained Earnings | 296.56 | 264.3 | 238.39 | 213.69 | 193.04 | 170.63 |
Treasury Stock | -1.3 | -17.66 | -18.91 | -4.38 | - | - |
Comprehensive Income & Other | 0.92 | 2.3 | 3.49 | 2.98 | 2.36 | -0.88 |
Total Common Equity | 1,084 | 1,025 | 973.38 | 955.85 | 855.05 | 813.99 |
Minority Interest | 30.92 | 34.25 | 28.37 | 24.25 | 33.67 | 32.38 |
Shareholders' Equity | 1,115 | 1,060 | 1,002 | 980.11 | 888.72 | 846.38 |
Total Liabilities & Equity | 1,696 | 1,629 | 1,451 | 1,429 | 1,265 | 1,138 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 43.34 | 43.79 | 46.13 | 111.62 | 80.84 | 31.5 |
Net Cash (Debt) | 364.95 | 337.78 | 247.68 | 292.92 | 271.78 | 373.02 |
Net Cash Growth | 32.64% | 36.38% | -15.44% | 7.78% | -27.14% | 194.69% |
Net Cash Per Share | 0.95 | 0.88 | 0.65 | 0.79 | 0.74 | 1.07 |
Filing Date Shares Outstanding | 381.85 | 383.2 | 380.5 | 379.34 | 368.39 | 366.04 |
Total Common Shares Outstanding | 381.85 | 383.07 | 380.5 | 379.34 | 368.39 | 366.04 |
Working Capital | 493.49 | 435.4 | 382.76 | 457.67 | 401.02 | 429.26 |
Book Value Per Share | 2.84 | 2.68 | 2.56 | 2.52 | 2.32 | 2.22 |
Tangible Book Value | 1,035 | 972.62 | 923.97 | 905.83 | 804.59 | 763.4 |
Tangible Book Value Per Share | 2.71 | 2.54 | 2.43 | 2.39 | 2.18 | 2.09 |
Buildings | - | 186.64 | 194.4 | 157.85 | 153.65 | 164.4 |
Machinery | - | 162.77 | 158.82 | 152.95 | 133.7 | 113.31 |
Construction In Progress | - | 7.5 | - | 120.6 | 92.39 | 11.43 |